Back
ESC2025 Premium Access

MyD-88/NLRP-3 inhibition by dapagliflozin protects against anthracycline and trastuzumab cardiotoxicity in preclinical models

Session: Cardio-oncology challenges
Topic: Cardio-Oncology
Speaker: Doctor N. Maurea (Naples, IT)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Nicola Maurea

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)
3 presentations
2 followers

4 more presentations in this session

Biomarker and imaging characterisation of inflammatory atheroma in patients receiving immunotherapy and angiogenesis inhibitors (BIOCAPRI): a prospective study using positron emission tomography

Speaker: Doctor S. Rankin (Glasgow, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Predicting Cardiovascular Risk in Patients with Prostate Cancer Receiving Abiraterone or Enzalutamide by Using Machine Learning

Speaker: Doctor D. Chen (New Taipei City, TW)

Access
Abstract
Slides
Video
Like
Thumbnail

Surveillance of left ventricular function among asymptomatic cancer survivors

Speaker: Doctor C. Soh (Melbourne, AU)

Access
Abstract
Slides
Video
Like
Thumbnail

Cardiovascular risk profiling in allogenic hematopoietic stem cell transplantation survivors

Speaker: Mr M. Mutti (Basel, CH)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Cardio-oncology challenges

Speakers: Doctor N. Maurea, Doctor S. Rankin, Doctor D. Chen, Doctor C. Soh, Mr M. Mutti
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources